Gaithersburg, MD, United States of America

Bret Sellman

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bret Sellman

Introduction

Bret Sellman is a notable inventor based in Gaithersburg, Maryland. With an impressive total of 15 patents to his name, he has made significant contributions to the fields of medicine and biotechnology. His work primarily focuses on the development of therapeutic antibodies aimed at combating infections.

Latest Patents

Among his latest patents is a method for decreasing infections in patients colonized by targeting anti-alpha toxin antibodies or their antigen-binding fragments. This innovative approach aims to reduce the incidence of infections associated with such colonizations. Another notable patent involves the development of a monoclonal antibody that specifically binds to the clumping factor A protein, which could be crucial in treating infections by utilizing this antibody in combination with other therapeutic agents. Furthermore, he has contributed to the creation of bispecific monoclonal antibodies that target both clumping factor A and alpha toxin proteins, broadening the potential for treating various infections.

Career Highlights

Bret Sellman has had a commendable career, with key roles in prominent organizations such as MedImmune Limited and Humabs Biomed SA. His expertise in antibody development and infectious disease prevention positions him as a leader in his field. His innovative work has garnered recognition and respect within the scientific community.

Collaborations

Throughout his career, Sellman has collaborated with talented individuals including Christine Tkaczyk and Partha S. Chowdhury. These collaborations have further enhanced his research and development initiatives, leading to groundbreaking advancements in the industry.

Conclusion

Bret Sellman's extensive portfolio of patents and his impactful career reflect his dedication to innovation in the medical field. His advancements in therapeutic antibodies not only showcase his talents as an inventor but also contribute significantly to improving patient outcomes and addressing critical health challenges. With ongoing research and collaboration, the future holds much promise for further innovations from Bret Sellman.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…